Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith R Walley

Showing results (171-180 of 220) with videos related to

Pageof 22
Sort By:
Atherosclerosis|October 7, 2022
Modulation of vascular endothelial inflammatory response by proprotein convertase subtilisin-kexin type 9Alex K K Leung, Yuan Chao Xue, Antyrah de Guzman, et al.
Critical Care Medicine|October 26, 2019
Very Low Density Lipoprotein Receptor Sequesters Lipopolysaccharide Into Adipose Tissue During SepsisTadanaga Shimada, Elena Topchiy, Alex K K Leung, et al.
Scientific Reports|November 15, 2018
CETP genetic variant rs1800777 (allele A) is associated with abnormally low HDL-C levels and increased risk of AKI during sepsisKelly Roveran Genga, Mark Trinder, HyeJin Julia Kong, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|October 28, 2004
The prediction of adverse maternal outcomes in preeclampsiaPeter von Dadelszen, Laura A Magee, Rajashree M Devarakonda, et al.
American Journal of Respiratory and Critical Care Medicine|September 30, 2017
Cellular Immunotherapy for Septic Shock. A Phase I Clinical TrialLauralyn A McIntyre, Duncan J Stewart, Shirley H J Mei, et al.
Critical Care Medicine|February 6, 2019
Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock PatientsKenny Schlosser, Jia-Pey Wang, Claudia Dos Santos, et al.
Elife|November 22, 2016
Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trialManoj M Lalu, Katrina J Sullivan, Shirley Hj Mei, et al.
Critical Care Medicine|February 25, 2009
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shockJames A Russell, Keith R Walley, Anthony C Gordon, et al.
American Journal of Respiratory and Critical Care Medicine|October 16, 2018
Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in SepsisMark Trinder, Kelly R Genga, HyeJin Julia Kong, et al.
Science Translational Medicine|October 17, 2014
PCSK9 is a critical regulator of the innate immune response and septic shock outcomeKeith R Walley, Katherine R Thain, James A Russell, et al.
Pageof 22

Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
Atherosclerosis|October 7, 2022
Modulation of vascular endothelial inflammatory response by proprotein convertase subtilisin-kexin type 9Alex K K Leung, Yuan Chao Xue, Antyrah de Guzman, et al.
Critical Care Medicine|October 26, 2019
Very Low Density Lipoprotein Receptor Sequesters Lipopolysaccharide Into Adipose Tissue During SepsisTadanaga Shimada, Elena Topchiy, Alex K K Leung, et al.
Scientific Reports|November 15, 2018
CETP genetic variant rs1800777 (allele A) is associated with abnormally low HDL-C levels and increased risk of AKI during sepsisKelly Roveran Genga, Mark Trinder, HyeJin Julia Kong, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|October 28, 2004
The prediction of adverse maternal outcomes in preeclampsiaPeter von Dadelszen, Laura A Magee, Rajashree M Devarakonda, et al.
American Journal of Respiratory and Critical Care Medicine|September 30, 2017
Cellular Immunotherapy for Septic Shock. A Phase I Clinical TrialLauralyn A McIntyre, Duncan J Stewart, Shirley H J Mei, et al.
Critical Care Medicine|February 6, 2019
Effects of Mesenchymal Stem Cell Treatment on Systemic Cytokine Levels in a Phase 1 Dose Escalation Safety Trial of Septic Shock PatientsKenny Schlosser, Jia-Pey Wang, Claudia Dos Santos, et al.
Elife|November 22, 2016
Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trialManoj M Lalu, Katrina J Sullivan, Shirley Hj Mei, et al.
Critical Care Medicine|February 25, 2009
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shockJames A Russell, Keith R Walley, Anthony C Gordon, et al.
American Journal of Respiratory and Critical Care Medicine|October 16, 2018
Cholesteryl Ester Transfer Protein Influences High-Density Lipoprotein Levels and Survival in SepsisMark Trinder, Kelly R Genga, HyeJin Julia Kong, et al.
Science Translational Medicine|October 17, 2014
PCSK9 is a critical regulator of the innate immune response and septic shock outcomeKeith R Walley, Katherine R Thain, James A Russell, et al.
Pageof 22